A biopharmaceutical company focused on developing a portfolio of internally discovered product candidates that utilize the body's natural nutrient transporter mechanisms to improve the therapeutic benefits of drugs.
The best Bull and Bear pitches based on recency and number of recommendations.
I hadn't reviewed Xenoport since April when I heard about the stock rising substantially after hours in late December, apparently solely because of a CNBC tweet that the stock was an RBC analyst's sleeper pick for 2015. I immediately shorted a… More
No matter how many times Xenoport fails, traders don't seem to want to give up on this stub. Here's a little history:12/08: Arbaclofen fails in GERD2/10: FDA issues CRL for Horizant for restless legs7/10: Horizant fails in migraine3/11: Arbaclofen… More
Read the most recent pitches from players about XNPT.DL.
Find the members with the highest scoring picks in XNPT.DL.
See what the Wall Street professionals think, according to their public statements and filings.